Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
121-135 of 137
Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
MinuteCE®Monitoring and Managing Treatment-Related Adverse Effects Associated With HER2-Directed Agents
Shubham Pant, MD, MBBS
Ritu Salani, MD
Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
MinuteCE®Patient Case: How Do HER2-Directed Therapies Fit Into the Biliary Tract Cancer Treatment Landscape?
Ritu Salani, MD
Shubham Pant, MD, MBBS
Ritu Salani, MD
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
MinuteCE®HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps
Shubham Pant, MD, MBBS
Secondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
CME/CESecondary Hyperparathyroidism: A Hidden Danger in Chronic Kidney Disease
Mario Cozzolino, MD, PhD
Jan T. Kielstein, MD, FASN, FERA
Sara A. Hurvitz, MD, FACP
- advertisement
Justin Gainor, MD
Justin Gainor, MD
Sara A. Hurvitz, MD, FACP
Jaffer Ajani, MD
Justin Gainor, MD
Sara A. Hurvitz, MD, FACP
Gopa Iyer, MD
Gopa Iyer, MD
Jaffer Ajani, MD
- advertisement
Sara A. Hurvitz, MD, FACP
Gopa Iyer, MD
Justin Gainor, MD
